Caffeic acid-pYEEIE (TFA)

Caffeic acid-pYEEIE TFA, a non-phosphopeptide inhibitor, exhibits potent binding affinity for the GST-Lck-SH2 domain[1].

Product Specifications

UNSPSC

12352209

Target

Src

Type

Peptides

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/caffeic-acid-pyeeie-tfa.html

Purity

98.47

Solubility

H2O : 25 mg/mL (ultrasonic)

Smiles

O=C(O)CC[C@@H](C(O)=O)NC([C@H]([C@@H](C)CC)NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CC1=CC=C(OP(O)(O)=O)C=C1)NC(/C=C/C2=CC=C(O)C(O)=C2)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O

Molecular Formula

C41H51F3N5O21P

Molecular Weight

1037.83

References & Citations

[1]See-Hyoung Park, et al. Design and characterization of non-phosphopeptide inhibitors for Src family SH2 domains. Bioorg Med Chem Lett. 2002 Oct 7;12 (19) :2711-4.